Sponsor

Curium Austria GmbH

Austria Grazer Strasse 18, 8071, Austria

About the sponsor

Curium Austria GmbH is involved in clinical research focused on prostate cancer, with interest in diagnostic imaging for men with clinical suspicion of disease and elevated PSA or PSA density. The research activity centres on identifying clinically significant disease in the setting of equivocal MRI findings and PI-RADS-based assessment.

Positron emission tomography
Computed tomography
Molecular imaging
Multiparametric MRI

The sponsor’s research interest includes the clinical use of 18F-labelled PET tracers for localising clinically significant prostate cancer in patients with indeterminate imaging findings.

About Specializations

Curium Austria GmbH runs clinical trials in conditions such as Prostate cancer, among others.

Prostate cancer

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Prostate cancer

Not recruiting

InvestigationalNo placebo

Study of Florastamin (18F) PET/CT Imaging for Detection of Significant Prostate Cancer in Patients with Elevated PSA Levels and Unclear MRI Results

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:(9S,13S)-1-(1-(2-(2-(2-[18F]Fluoroethoxy)Ethoxy)Ethyl)-1H-1,2,3-Triazol-4-Yl)-3,11-Dioxo-2,4,10,12-Tetraazapentadecane-9,13,15-Tricarboxylicacid
Sponsor:Curium Austria GmbH

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →